8-K current report · filed Sep 9, 2026

Xylem Inc. (XYL) 8-K Current Report: September 9, 2026

Item 1.01Item 1.02Item 2.03XYL overview

Short answer

Xylem Inc. (XYL) filed an 8-K current report with the SEC on September 9, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation). $1.5B senior unsecured revolving facility supports working capital and general corporate purposes.

Xylem Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • $1.5B senior unsecured revolving facility supports working capital and general corporate purposes
  • Expansion option of up to $500M increases maximum commitments to $2B
  • Five-year maturity provides substantial liquidity without immediate borrowing
  • Pricing tied to credit rating and sustainability adjustments, affecting future financing costs
  • Debt-to-EBITDA covenant and customary restrictions constrain leverage and secured borrowing flexibility

Item 1.02 · Termination of a Material Definitive Agreement

  • Xylem terminated its 2023 senior unsecured revolving facility on September 8, 2026
  • Replaced facility provided $1,000,000,000 of revolving borrowing capacity
  • Expansion feature allowed up to $1,300,000,000 total commitments with lender consent
  • Termination coincided with entry into the 2026 Credit Agreement, signaling refinancing of corporate liquidity backstop

Item 2.03 · Creation of a Direct Financial Obligation

  • Item 2.03 links to Item 1.01, indicating a material agreement created or amended a direct financial obligation
  • Financial obligation terms require review of the referenced Item 1.01 disclosure for amount, maturity, interest rate and purpose

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Xylem Inc. 8-K filings

Get the next XYL 8-K as it lands

Follow XYL for push alerts, or ask the research agent what this filing means.